Trial Profile
Effect of strontium ranelate (2g per day) in the management of long bone fractures with delayed-union or non union: an international open label study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Oct 2022
Price :
$35
*
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Servier
- 11 Dec 2015 New trial record